Single dose pharmacokinetics, pharmacodynamics, tolerability and safety of BAY 60-5521, a potent inhibitor of cholesteryl ester transfer protein.
about
Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDLThe prevention and regression of atherosclerotic plaques: emerging treatments.Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk.Prediction of a potentially effective dose in humans for BAY 60-5521, a potent inhibitor of cholesteryl ester transfer protein (CETP) by allometric species scaling and combined pharmacodynamic and physiologically-based pharmacokinetic modellingOn- and off-target pharmacology of torcetrapib: current understanding and implications for the structure activity relationships (SAR), discovery and development of cholesteryl ester-transfer protein (CETP) inhibitors.Safety of inhibition of cholesteryl ester transfer protein with anacetrapib: the DEFINE study.Low-density lipoprotein lowering in 2013 by nonstatin agents: the discovery and development of promising novel targeted therapies.Emerging drugs for hyperlipidaemia: an update.Chemical Genetic Approaches for the Investigation of Neutral Lipid Metabolism.Editors' pick 2012.
P2860
Q26801507-D854DE2E-C53A-4EDA-9E41-DD944DC9FCD5Q27691367-8471C62E-7C37-4D6A-B6E0-7D354BDD8134Q34253290-CE52CBC8-2332-468B-8F6B-081849A1EB32Q35718576-7A036BA2-BCC4-407F-9DD6-A1AB1FB652E9Q37987207-ABC2EA11-1101-4588-A864-865C9D06E4A7Q38048831-C3432696-5322-42A8-8DD1-0992592741B4Q38098501-5387F58E-E703-4BE2-82A9-588FF747D561Q38263909-24794937-6BED-4113-8E74-4BD6749C208BQ38682493-F93F4A84-1D64-4365-A691-E1965AF6D750Q42976095-3DF4801D-8B3E-4724-B6DC-43132AFDB99E
P2860
Single dose pharmacokinetics, pharmacodynamics, tolerability and safety of BAY 60-5521, a potent inhibitor of cholesteryl ester transfer protein.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Single dose pharmacokinetics, ...... steryl ester transfer protein.
@en
type
label
Single dose pharmacokinetics, ...... steryl ester transfer protein.
@en
prefLabel
Single dose pharmacokinetics, ...... steryl ester transfer protein.
@en
P2093
P2860
P1476
Single dose pharmacokinetics, ...... steryl ester transfer protein.
@en
P2093
Anja Schaefer
Carsten Schmeck
Christian Kohlsdorfer
Georg Wensing
Matthias Ludwig
Michael-Friedrich Boettcher
Olaf Weber
Roland Heinig
Sabine Gelfert-Peukert
P2860
P304
P356
10.1111/J.1365-2125.2011.04083.X
P407
P577
2012-02-01T00:00:00Z